This small randomized trial evaluated the potential benefits of ghrelin, an anti-inflammatory agent, in reducing the SIRS response after esophagectomy. The ghrelin group had a reduced SIRS duration, lower CRP levels, and lower IL-6 levels compared to controls. Pulmonary complications were reduced in the ghrelin group, but other complication incidences were similar.
You are here:
Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy
Submitted by: Mark Ferguson
Source: Annals of Surgery
Keywords:
Author(s): Takata, Akihiro; Takiguchi, Shuji; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Kangawa, Kenji; Doki, Yuichiro
